Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.43B |
| 3 |
Boeing
BA
|
+$283M |
| 4 |
CrowdStrike
CRWD
|
+$251M |
| 5 |
Coinbase
COIN
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$845M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$837M |
| 3 |
Broadcom
AVGO
|
+$691M |
| 4 |
NVIDIA
NVDA
|
+$662M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$660M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 93.75% |
| 2 | Technology | 1.85% |
| 3 | Consumer Discretionary | 1.02% |
| 4 | Financials | 0.76% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11601
CALL
Ocugen
OCGN
$465M
| $17.6K | ﹤0.01% |
17,800
-79,600
| -82% | -$109K |
|
|
TOUR
11602
Tuniu
TOUR
$51.5M
| $17.3K | ﹤0.01% |
1,220
-5,823
| -83% | -$50.7K |
|
11603
CALL
SCYNEXIS
SCYX
$54.9M
| $17.3K | ﹤0.01% |
1,450
-813
| -36% | -$11.5K |
|
|
RGLS
11604
PUT
DELISTED
Regulus Therapeutics
RGLS
| $17.3K | ﹤0.01% |
11,000
-15,000
| -58% | -$24.8K |
|
|
BCTX
11605
Briacell Therapeutics
BCTX
$32.3M
| $17.2K | ﹤0.01% |
93
+11
| +13% | +$1.24K |
|
11606
Playboy Inc
PLBY
$144M
| $17.2K | ﹤0.01% |
22,704
-65,316
| -74% | -$46.7K |
|
|
NWGL
11607
CL Workshop Group Ltd
NWGL
$13.7M
| $16.8K | ﹤0.01% |
10,177
-9,210
| -48% | -$17K |
|
|
NBP
11608
NovaBridge Biosciences American Depositary Shares
NBP
$219M
| $16.6K | ﹤0.01% |
13,351
-17,715
| -57% | -$22.2K |
|
11609
Cytosorbents Corp
CTSO
$21.4M
| $16.6K | ﹤0.01% |
11,033
-78,755
| -88% | -$86.4K |
|
11610
PUT
BARK
BARK
$98M
| $16.5K | ﹤0.01% |
505
-1,550
| -75% | -$50.4K |
|
|
USAS
11611
Americas Gold and Silver
USAS
$1.94B
| $16.3K | ﹤0.01% |
21,300
+1,054
| +5% | +$674 |
|
11612
Apyx Medical
APYX
$126M
| $16.2K | ﹤0.01% |
13,070
-61,727
| -83% | -$77.9K |
|
|
URG
11613
Ur-Energy
URG
$609M
| $16.1K | ﹤0.01% |
13,494
-51,088
| -79% | -$61K |
|
11614
Energy Focus
EFOI
$18.5M
| $15.8K | ﹤0.01% |
13,240
+817
| +7% | +$1.12K |
|
11615
Mustang Bio
MBIO
$4.17M
| $15.6K | ﹤0.01% |
+1,326
| New | +$21.9K |
|
11616
CALL
Arena Group
AREN
$44.8M
| $15.6K | ﹤0.01% |
+19,200
| New | +$16.7K |
|
11617
AtaiBeckley Inc
ATAI
$2.73B
| $15.5K | ﹤0.01% |
13,337
-14,297
| -52% | -$19.1K |
|
11618
Interactive Strength
TRNR
$4.21M
| $15.5K | ﹤0.01% |
+1
| New | +$40.8K |
|
|
HYPD
11619
Hyperion DeFi Inc
HYPD
$56.3M
| $15.4K | ﹤0.01% |
374
-718
| -66% | -$46.2K |
|
11620
Talphera
TLPH
$63.8M
| $15.4K | ﹤0.01% |
+18,014
| New | +$16.5K |
|
|
AIFU
11621
AIFU Inc
AIFU
$131M
| $15.3K | ﹤0.01% |
+27
| New | +$15.1K |
|
|
SPI
11622
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $15.1K | ﹤0.01% |
+35,562
| New | +$13.1K |
|
|
QVCGA
11623
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $15K | ﹤0.01% |
492
-4,006
| -89% | -$127K |
|
|
NEUP
11624
Neuphoria Therapeutics
NEUP
$20.4M
| $14.9K | ﹤0.01% |
+2,845
| New | +$22.5K |
|
11625
CALL
CPS Technologies
CPSH
$76M
| $14.8K | ﹤0.01% |
+10,400
| New | +$15.7K |
|
Similar funds
Jeff Yass's Q3 2024 Portfolio in Review
As of Q3 2024, Jeff Yass held 13,475 positions worth $572B, up 6.6% from $537B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Jeff Yass's Q3 2024 filing shows 1,572 new, 5,247 increased, 4,924 reduced and 1,625 closed positions. Its largest new stake was Camtek: 408,771 shares worth $32.6M. The largest sale was Apple, an estimated $845M.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2024 buy was Camtek: 408,771 shares worth $32.6M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.58B increase.
- Jeff Yass's biggest Q3 2024 reduction was Apple, cutting an estimated $845M.
- Jeff Yass fully exited iShares Convertible Bond ETF in Q3 2024, selling an estimated $80.5M.
- Jeff Yass's ten largest holdings make up 25% of its $572B portfolio in Q3 2024.
- Jeff Yass opened 1,572 new positions and closed 1,625 in Q3 2024.
- Jeff Yass's portfolio value rose 6.6% quarter-over-quarter to $572B.
Based on Susquehanna International Group's 13F filing for Q3 2024, filed 14 Nov 2024.